Gingicaine Gel, Cherry Gel
Product Images NDC 10129-715

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Gingicaine Gel, Cherry (NDC 10129-715). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gingi-pak A Division Of The Belport, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Keep Out Of Reach Of Children (Children Page 001)

Text panel containing a warning for Gingicaine Gel products, advising to keep out of reach of children and to call a doctor immediately if the gel is ingested or swallowed by a child, with instructions to follow directions accordingly.*

FDA Label Image

Contraindications

Drug facts text panel presenting contraindications for GingiCaine gel, specifying it should not be used in patients with hypersensitivity to ester-type local anesthetics, nor for teething or infants and children under 2 years old.*

FDA Label Image

Gingicaine Cherry Jar Label

Drug Facts panel for GingiCaine Gel, Cherry flavor, a topical anesthetic gel with 20% benzocaine as the active ingredient. The label details drug uses for reducing pain or discomfort from minor dental procedures, warnings, allergy alerts, directions for use, dosage, administration instructions, and cautions. The label also includes product handling notes and manufacturer contact information.*

FDA Label Image

Active Ingredients (Gingicaine Active Ingredients 001)

This text panel shows the active ingredient and purpose for GingiCaine gel, Cherry flavor. It lists Benzocaine 20% w/v as the active ingredient and indicates its purpose as an oral anesthetic.*

FDA Label Image

Allergy Alert (Gingicaine Allergy Alert 001)

A warning text panel titled 'Allergy alert' advising not to use the product if there is a history of allergy to any 'caine' local anesthetics or FD&C Red #40.*

FDA Label Image

Avoid Excessive Heat (Gingicaine Avoid Excessive Heat)

A text panel titled 'Avoid Excessive heat' warning against exposure above 40°C (104°F). It provides storage temperature instructions to maintain product quality.*

FDA Label Image

Consult A Doctor Promptly (Gingicaine Consult A Doctor Gingicaine)

Text panel providing warnings and precautions for GingiCaine gel, Cherry flavor, advising to consult a doctor if certain symptoms like severe sore throat, fever, rash, or persistent mouth sores occur, and cautioning against eye contact, keeping out of reach of children, accidental ingestion, and exceeding recommended dosage.*

FDA Label Image

Dosage And Administration001 (Gingicaine Dosage And Admin 001)

A partial text panel titled 'Dosage & Administration,' advising that mucosa should be dried prior to application and removal of excess saliva. It outlines initial steps for the use of a dental gel product.*

FDA Label Image

Dosage And Administration002 (Gingicaine Dosage And Admin 002)

This text panel provides directions for use and precautions for GingiCaine gel, emphasizing application techniques, dosage limits, and age restrictions. It advises applying the gel to the affected area, remaining in place for at least one minute, usage frequency up to four times daily, and cautions for children under 2 years to consult a healthcare professional.*

FDA Label Image

​indications (Gingicaine Indications 001)

Text panel titled 'Indications' describing the use of GingiCaine gel for anesthesia of mucous membranes of the oropharynx. It outlines the gel's role in minimizing pain from ulcers, needle puncture, deep scaling procedures, application of matrix bands, and aiding in impressions or intraoral radiographs for patients with excessive gag reflex.*

FDA Label Image

Precautions (Gingicaine Precaution 001)

A text panel containing precautions for use of a local anesthetic gel. It advises dentists to avoid application on severely traumatized mucosal areas or posterior pharynx due to risk of obtunding protective reflexes, cautions use in patients with known drug sensitivities, especially to ester-type anesthetics, and to avoid contact with all local anesthetics to prevent sensitization.*

FDA Label Image

Uses (Gingicaine Uses 001)

A text panel listing the uses of the product. It states that the product is intended to reduce pain or discomfort caused by minor dental procedures, minor gum injury, canker sores, sore throat, and minor mouth or gum irritations caused by dentures or orthodontic appliances.*

FDA Label Image

Inactive Ingredients (Inactive Ingredient Page 001)

Text panel listing inactive ingredients: Polyethylene Glycol 3350, Polyethylene Glycol 400, and Potassium Sodium Saccharate. The panel appears to be part of an ingredient or formulation list for a pharmaceutical product.*

FDA Label Image

Purpose (Purpose Page 001)

This text panel explains that Gingicaine Gel is a topical anesthetic used by dentists just prior to an injection, typically applied on a patient's gum for dental use.*

FDA Label Image

Warnings

A warning text panel advising that the product is for external use only and may cause methemoglobinemia, a serious condition. Symptoms requiring immediate medical attention are listed, including pale or blue skin, headache, rapid heart rate, shortness of breath, dizziness, and fatigue. It also warns against use in children under 2 years of age.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.